Reinventing patient recruitment: revolutionary ideas for clinical trial success

During the last five years, clinical research and development costs have risen exponentially without a proportionate increase in the number of new medications.

While patient recruitment for clinical studies is only one component in the development of a new medicine or treatment, it is one of the most significant bottlenecks in the overall drug development process.

Now it is imperative that industry leaders see beyond reactive measures and recognize that advancing their approach to patient recruitment is absolutely essential to advancing medicine and continuing the stability of their corporate brand across the globe.